Nasdaq
AMLX
Amylyx Pharmaceuticals, Inc.
- Health Care
- Listed 2022
- 1 day
- +10.7%
- 1 month
- +33.1%
- 1 year
- +195%
$24.19 · Mkt cap $2.69B
At the 6 Aug 2026 close
Nasdaq
Amylyx Pharmaceuticals, Inc.
$24.19 · Mkt cap $2.69B
At the 6 Aug 2026 close
Amylyx Pharmaceuticals, Inc. trades under the ticker AMLX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2022. Its market capitalisation is $2.69B. The last closing price was $24.19, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +195%, and +33.1% over the past month. Returns are price returns and exclude dividends.
This page exists because AMLX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.